 



Tuesday


July 5, 1994





Part IV


Department of Health and Human Services





National Institutes of Health





Guidelines for Research Involving Recombinant DNA Molecules (NIH 
Guidelines); Notice









Federal Register

/Vol. 59, No. 127/Tuesday, July 5, 
1994/Notices





<USDEPT>DEPARTMENT OF HEALTH AND HUMAN SERVICES </USDEPT>




<USBUREAU>National Institutes of Health</USBUREAU>

Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines) 


June 1994.


These NIH Guidelines supersede all earlier versions and shall be in effect until further notice. 


Table of Contents 


Section I. Scope of the NIH Guidelines 
Section IA. Purpose 
Section IB. Definition of Recombinant DNA Molecules 
Section IC. General Applicability 
Section ID. General Definitions 
Section II. Containment 
Section III. Experiments Covered by the NIH Guidelines 
Section IIIA. Experiments that Require Institutional Biosafety Committee Approval, RAC Review, and NIH
Approval Before Initiation 
Section IIIB. Experiments that Require NIH/ORDA and Institutional Biosafety Committee Approval Before
Initiation 
Section IIIB1. Experiments Involving the Cloning of Toxin Molecules with LD

50

 of Less than 100 Nanograms Per Kilogram Body Weight 
Section IIIB2. Accelerated Review of Human Gene Transfer Experiments 
Section IIIB3. Minor Modifications to Human Gene Transfer Experiments 
Section IIIC. Experiments that Require Institutional Biosafety Committee 
Approval Before Initiation 
Section IIIC1. Experiments Using Human or Animal Pathogens (Class 2, Class 3, Class 4, or Class 5) Agents
as Host-Vector Systems 
Section IIIC2. Experiments in which DNA from Human or Animal Pathogens (Class 2, Class 3, Class 4, or
Class 5) Agents is Cloned into Nonpathogenic Prokaryotic or Lower Eukaryotic Host-Vector Systems 
Section IIIC3. Experiments Involving the Use of Infectious Animal or Plant DNA or RNA Viruses or Defective
Animal or Plant DNA or RNA Viruses in the Presence of Helper Virus in Tissue Culture Systems 
Section IIIC4. Experiments Involving Whole Animals 
Section IIIC5. Experiments Involving Whole Plants 
Section IIIC6. Experiments Involving More than 10 Liters of Culture 
Section IIIC7. Human Gene Transfer Experiments Not Covered by Section IIIA2, IIIB2,
IIIB3, and Not Considered Exempt under Section VU 
Section IIID. Experiments that Require Institutional Biosafety Committee Notice Simultaneous with Initiation

Section IIID1. Experiments Involving the Formation of Recombinant DNA Molecules Containing No More
than Two-Thirds of the Genome of any Eukaryotic Virus 
Section IIID2. Experiments Involving Whole Plants 
Section IIIE. Exempt Experiments 
Section IV. Roles and Responsibilities 
Section IVA. Policy 
Section IVB. Responsibilities of the Institution 
Section IVB1. General Information 
Section IVB2. Institutional Biosafety Committee (IBC) 
Section IVB3. Biological Safety Officer (BSO) 
Section IVB4. Principal Investigator (PI) 
Section IVC. Responsibilities of the National Institutes of Health (NIH) 
Section IVC1. NIH Director 
Section IVC1a. General Responsibilities 
Section IVC1b. Specific Responsibilities 
Section IVC1b(1). Major Actions 
Section IVC1b(2). Minor Actions 
Section IVC2. Recombinant DNA Advisory Committee (RAC) 
Section IVC3. Office of Recombinant DNA Activities (ORDA) 
Section IVC4. Other NIH Components 
Section IVD. Compliance with the NIH Guidelines 
Section IVE. Voluntary Compliance 
Section V. Footnotes and References of Sections IIV 



